Escitalopram Efficacy in Depression

Antidepressant pharmacogenetics

(2013) Ajeet B. Singh et al.   CURRENT OPINION IN PSYCHIATRY

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

(2013) Chee Ng et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Association between Serotonin Transporter-Linked Polymorphic Region and Escitalopram Antidepressant Treatment Response in Korean Patients with Major Depressive Disorder

(2012) Eun-Soo Won et al.   NEUROPSYCHOBIOLOGY

Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

(2012) Y Ji et al.   PHARMACOGENOMICS JOURNAL

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

(2012) A B Singh et al.   Translational Psychiatry

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

(2011) Stefano Porcelli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Rare genotype combination of the serotonin transporter gene associated with treatment response in severe personality disorder

(2010) Nader Perroud et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Moderation of antidepressant response by the serotonin transporter gene

(2009) Patricia Huezo-Diaz et al.   BRITISH JOURNAL OF PSYCHIATRY

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

(2009) Eduard Maron et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Genetic Structure of Europeans: A View from the North–East

(2009) Mari Nelis et al.   PLoS One